Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-12

Clinical Trial Update: Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor [NA]

View source ↗

Summary

A clinical trial update from Baker Heart and Diabetes Institute shows the study is recruiting to assess whether managing heart failure as a modifiable risk fact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Heart Failure, Cognitive Impairment | NA | Status: RECRUITING